Follow Us      

LOGIN
 
Share Page:
Back

Volume 33 , Issue 1
January/February 2013

Pages 4349


Subepithelial Connective Tissue Graft with Growth Factor for the Treatment of Maxillary Gingival Recession Defect

Robert P. Rubins, DDS, MScD/Paul N. Tolmie, DDS/Kenneth T. Corsig, DMD, MHS/Eric N. Kerr, DDS, MS/David M. Kim, DDS, DMSc


DOI: 10.11607/prd.0000

Gingival recession is a challenging defect for clinicians to treat effectively. A number of recent systematic reviews have identified the connective tissue graft (CTG) in combination with coronally advanced flaps (CAFs) as the most consistently effective treatment for Miller Class I and II defects across all outcome measures. Recent advances in recombinant growth factor technology may provide opportunities for improved outcomes in conjunction with CAF + CTG procedures. In this prospective consecutive case series, recombinant human platelet-derived growth factor BB (rhPDGF-BB) was combined with CTGs for the treatment of Miller Class I or II gingival recession defects. Improved outcomes were seen for keratinized tissue gains and percent root coverage at 6 months postsurgery when compared to historic norms. All other outcome parameters appeared equivalent between the two treatment approaches. The addition of rhPDGF-BB appeared to improve early wound healing as well. (Int J Periodontics Restorative Dent 2013;33:4349. doi: 10.11607/prd.0000)


Full Text PDF File | Order Article

 

 
Get Adobe Reader
Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.

 

© 2014 Quintessence Publishing Co, Inc

PRD Home
Current Issue
Ahead of Print
Archive
Author Guidelines
About
Accepted Manuscripts
Submission Form
Submit
Reprints
Permission
Advertising
Quintessence Home
Terms of Use
Privacy Policy
About Us
Contact Us
Help